Se ha publicado un nuevo artículo con datos de ENEIDA en la revista Journal of Crohn’s and Colitis:

Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry. (REINA)